Congruent with this idea, we showed MTH1 mRNA levels positively correlate with KRAS levels, even in early-stage human NSCLC tumors, and that introduction of oncogenic RAS is sufficient to upregulate MTH1 mRNA and protein expression [27]. Here, KRAS is linked to non-small cell lung carcinoma.